SEC Form 5 · accession 0001209191-15-010437
Evoke Pharma Inc · EVOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Gonyer
Officer — President and CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 6, 2015 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403708
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2014 | J | 164,000 | $0.00 | D | 281,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents transfer of shares to Reporting Person's ex-spouse pursuant to a Marital Settlement Agreement.